Alyeska Investment Group’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Alyeska Investment Group’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-92,225	Closed	-$171K	–	535
2015 Q3	$171K	Buy	92,225 +8,439	+10%	+$20.1K	﹤0.01%	452
2015 Q2	$196K	Buy	83,786 +1,357	+2%	+$4.19K	﹤0.01%	476
2015 Q1	$361K	Buy	82,429 +6,061	+8%	+$30.4K	0.01%	478
2014 Q4	$368K	Sell	76,368 -2,828	-4%	-$12.7K	0.01%	457
2014 Q3	$329K	Sell	79,196 -3,747	-5%	-$17.5K	0.01%	365
2014 Q2	$489K	Buy	82,943 +7,284	+10%	+$41.3K	0.01%	380
2014 Q1	$483K	Sell	75,659 -51,841	-41%	-$468K	0.01%	309
2013 Q4	$1.21M	Buy	+127,500	New	+$995K	0.05%	260

Other funds holding TLOG

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Alyeska Investment Group's TLOG Position: Q4 2015 in Review

Alyeska Investment Group sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q4 2015, closing a stake of 92,225 shares — an estimated $171K sold.

Alyeska Investment Group first reported a position in TLOG in Q4 2013 and held it in 8 quarters. The position peaked at $1.21M in Q4 2013. 31 funds tracked by Wall St. Rank hold TLOG as of Q4 2015.

Alyeska Investment Group reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q4 2015 after selling out during the quarter.
Alyeska Investment Group sold 92,225 TetraLogic Pharmaceuticals Corporation shares in Q4 2015, an estimated $171K.
Alyeska Investment Group first reported a position in TetraLogic Pharmaceuticals Corporation in Q4 2013 and held it in 8 quarters.
Alyeska Investment Group's TetraLogic Pharmaceuticals Corporation position peaked at $1.21M in Q4 2013.
31 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q4 2015.

Based on Alyeska Investment Group's 13F filing for Q4 2015, filed 16 Feb 2016.